The Role of Interleukin-12 on Modulating Myeloid-Derived Suppressor Cells
Indiana University-Purdue University Indianapolis (IUPUI) === More than 200,000 American women are diagnosed with breast cancer each year. Although therapies effective in treating metastatic breast cancer currently exist, each year approximately 40,000 women die from this disease. Current evidence...
Main Author: | Steding, Catherine E. |
---|---|
Other Authors: | Kao, Chinghai |
Language: | en_US |
Published: |
2011
|
Subjects: | |
Online Access: | http://hdl.handle.net/1805/2491 |
Similar Items
-
Serum Levels of Il-12 and Il-23 in Breast Cancer Patients Infected with Toxoplasma gondii: A Case-Control Study
by: Maha Mustafa ASSIM, et al.
Published: (2020-12-01) -
Deciphering the Crosstalk Between Myeloid-Derived Suppressor Cells and Regulatory T Cells in Pancreatic Ductal Adenocarcinoma
by: Carole Siret, et al.
Published: (2020-01-01) -
Evaluation of the circulating levels of IL-12 and IL-33 in patients with breast cancer: influences of the tumor stages and cytokine gene polymorphisms
by: Abdollah Jafarzadeh, et al.
Published: (2015-12-01) -
"Recurrent Non-Typhoidal Salmonella Bacteremia in a Patient with Interleukin -12p40 Deficiency "
by: Batool Sharifi Mood, et al.
Published: (2004-12-01) -
Understanding the Differentiation, Expansion, Recruitment and Suppressive Activities of Myeloid-Derived Suppressor Cells in Cancers
by: Hui Xuan Lim, et al.
Published: (2020-05-01)